News Daily News PASCAL Pinpoints Patients With Strokes Causally Related to PFO Yael L. Maxwell December 20, 2021
Presentation TCT 2021 Evidence-Based Antiplatelet and Antithrombotic Therapy for TAVR Presenter: Stephan Windecker November 05, 2021
News Conference News TCT 2021 LAA Closure Feasible in Patients With Thrombus: Registry Michael O'Riordan October 13, 2021
News Daily News Valve-in-Valve TAVI Bests Redo SAVR in Short Term Michael O'Riordan September 20, 2021
News Conference News ESC 2021 Amulet IDE: LAA Occluder Performs Well Against Watchman Todd Neale August 30, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Daily News AHA Advice for Rare but Deadly Mechanical Complications of Acute MI L.A. McKeown June 18, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Daily News PFO Closure for Stroke Is Safe, Effective at 5 Years: REDUCE Yael L. Maxwell March 15, 2021